Cabometyx 40 MG tablet 30S
Ended Awarded
- Contract number
- SPE2DB25FYX49
- Awardee
-
DMS Pharmaceutical Group Inc. UEI PX72BSBQTKJ3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $16,483
Award facts
- Contract value 100% obligated
- $16,483.21 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Park Ridge, IL 60068, USA
Award details come from SAM.gov/FPDS.
About this award
DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, was awarded a delivery order valued at $16,483.21 by the Defense Logistics Agency on September 3, 2025, for the supply of Cabometyx 40 mg tablets (30-count units). This firm fixed-price delivery order, with an ultimate completion date of September 4, 2025, was issued without a set-aside designation. The award is issued under DMS Pharmaceutical Group's existing single-award Indefinite Delivery Contract with the DLA under the SPE2DB program, which carries a total value of $499,999,999 and remains valid through November 2026.
The delivery order reflects DMS Pharmaceutical Group's established role as a critical supplier within the federal pharmaceutical supply chain, providing prescription medications and medical supplies to Department of Defense healthcare facilities. Cabometyx (cabozantinib) is an oncology medication used in the treatment of certain cancers, consistent with the company's portfolio of specialized pharmaceutical products delivered to military health systems. The performance location is Park Ridge, Illinois, where DMS Pharmaceutical Group maintains its distribution operations serving federal healthcare needs nationwide.
Quick answers
Who was awarded contract SPE2DB25FYX49?
SPE2DB25FYX49 was awarded to DMS Pharmaceutical Group Inc. by Defense Logistics Agency (Department of Defense) on September 3, 2025.
How much is contract SPE2DB25FYX49 worth?
The government has obligated $16,483 on SPE2DB25FYX49.
Is contract SPE2DB25FYX49 an order under another contract?
Yes. SPE2DB25FYX49 is a delivery order under SPE2DB22D9133, an indefinite delivery contract.
Was contract SPE2DB25FYX49 competed?
The extent of competition for SPE2DB25FYX49 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award